Annual Accounts Receivable
$2.10 B
-$36.40 M-1.70%
December 31, 2023
Summary
- As of February 7, 2025, BIIB annual accounts receivable is $2.10 billion, with the most recent change of -$36.40 million (-1.70%) on December 31, 2023.
- During the last 3 years, BIIB annual accounts receivable has fallen by -$227.30 million (-9.77%).
- BIIB annual accounts receivable is now -15.51% below its all-time high of $2.49 billion, reached on December 31, 2018.
Performance
BIIB Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$1.99 B
-$90.10 M-4.34%
September 30, 2024
Summary
- As of February 7, 2025, BIIB quarterly accounts receivable is $1.99 billion, with the most recent change of -$90.10 million (-4.34%) on September 30, 2024.
- Over the past year, BIIB quarterly accounts receivable has dropped by -$90.10 million (-4.34%).
- BIIB quarterly accounts receivable is now -24.00% below its all-time high of $2.62 billion, reached on March 31, 2019.
Performance
BIIB Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
BIIB Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.7% | -4.3% |
| 3 y3 years | -9.8% | -4.3% |
| 5 y5 years | -15.5% | -4.3% |
BIIB Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.7% | +7.0% | -10.0% | +1.4% |
| 5 y | 5-year | -15.0% | +7.0% | -23.7% | +1.4% |
| alltime | all time | -15.5% | >+9999.0% | -24.0% | >+9999.0% |
Biogen Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.99 B(-4.3%) |
| Jun 2024 | - | $2.08 B(+3.9%) |
| Mar 2024 | - | $2.00 B(-4.8%) |
| Dec 2023 | $2.10 B(-1.7%) | $2.10 B(-5.0%) |
| Sep 2023 | - | $2.21 B(+4.0%) |
| Jun 2023 | - | $2.12 B(+4.7%) |
| Mar 2023 | - | $2.03 B(-5.1%) |
| Dec 2022 | $2.14 B(+8.9%) | $2.14 B(+7.7%) |
| Sep 2022 | - | $1.98 B(-1.0%) |
| Jun 2022 | - | $2.00 B(-0.9%) |
| Mar 2022 | - | $2.02 B(+3.0%) |
| Dec 2021 | $1.96 B(-15.7%) | $1.96 B(-7.6%) |
| Sep 2021 | - | $2.12 B(+0.6%) |
| Jun 2021 | - | $2.11 B(-5.1%) |
| Mar 2021 | - | $2.22 B(-4.4%) |
| Dec 2020 | $2.33 B(-5.8%) | $2.33 B(-8.8%) |
| Sep 2020 | - | $2.55 B(-0.9%) |
| Jun 2020 | - | $2.57 B(-1.1%) |
| Mar 2020 | - | $2.60 B(+5.4%) |
| Dec 2019 | $2.47 B(-0.6%) | $2.47 B(-1.8%) |
| Sep 2019 | - | $2.52 B(-0.1%) |
| Jun 2019 | - | $2.52 B(-3.8%) |
| Mar 2019 | - | $2.62 B(+5.3%) |
| Dec 2018 | $2.49 B(+7.1%) | $2.49 B(-1.6%) |
| Sep 2018 | - | $2.53 B(+3.8%) |
| Jun 2018 | - | $2.43 B(-2.4%) |
| Mar 2018 | - | $2.49 B(+7.5%) |
| Dec 2017 | $2.32 B(+33.1%) | $2.32 B(+11.2%) |
| Sep 2017 | - | $2.09 B(-2.2%) |
| Jun 2017 | - | $2.13 B(+16.8%) |
| Mar 2017 | - | $1.83 B(+4.8%) |
| Dec 2016 | $1.74 B(+13.0%) | $1.74 B(-1.7%) |
| Sep 2016 | - | $1.77 B(+9.0%) |
| Jun 2016 | - | $1.63 B(-4.9%) |
| Mar 2016 | - | $1.71 B(+10.9%) |
| Dec 2015 | $1.54 B(+19.3%) | $1.54 B(+16.1%) |
| Sep 2015 | - | $1.33 B(+1.3%) |
| Jun 2015 | - | $1.31 B(-5.7%) |
| Mar 2015 | - | $1.39 B(+7.6%) |
| Dec 2014 | $1.29 B(+56.8%) | $1.29 B(+18.4%) |
| Sep 2014 | - | $1.09 B(+8.9%) |
| Jun 2014 | - | $1.00 B(-1.6%) |
| Mar 2014 | - | $1.02 B(+23.5%) |
| Dec 2013 | $824.41 M(+20.0%) | $824.41 M(-7.5%) |
| Sep 2013 | - | $891.40 M(+3.5%) |
| Jun 2013 | - | $861.46 M(+14.3%) |
| Mar 2013 | - | $753.61 M(+9.7%) |
| Dec 2012 | $686.85 M(+17.5%) | $686.85 M(+3.8%) |
| Sep 2012 | - | $661.52 M(-3.3%) |
| Jun 2012 | - | $683.84 M(-0.1%) |
| Mar 2012 | - | $684.24 M(+17.0%) |
| Dec 2011 | $584.60 M | $584.60 M(+0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $581.05 M(-12.9%) |
| Jun 2011 | - | $666.96 M(-3.0%) |
| Mar 2011 | - | $687.61 M(+13.6%) |
| Dec 2010 | $605.33 M(+9.8%) | $605.33 M(-1.8%) |
| Sep 2010 | - | $616.70 M(+12.4%) |
| Jun 2010 | - | $548.89 M(-2.1%) |
| Mar 2010 | - | $560.78 M(+1.7%) |
| Dec 2009 | $551.21 M(+23.4%) | $551.21 M(+0.0%) |
| Sep 2009 | - | $551.00 M(+7.8%) |
| Jun 2009 | - | $511.29 M(+6.2%) |
| Mar 2009 | - | $481.21 M(+7.7%) |
| Dec 2008 | $446.67 M(+13.8%) | $446.67 M(-7.8%) |
| Sep 2008 | - | $484.64 M(+0.4%) |
| Jun 2008 | - | $482.80 M(+6.9%) |
| Mar 2008 | - | $451.48 M(+15.0%) |
| Dec 2007 | $392.65 M(+23.7%) | $392.65 M(+3.7%) |
| Sep 2007 | - | $378.81 M(+5.4%) |
| Jun 2007 | - | $359.52 M(+10.8%) |
| Mar 2007 | - | $324.57 M(+2.3%) |
| Dec 2006 | $317.35 M(+13.1%) | $317.35 M(+12.3%) |
| Sep 2006 | - | $282.52 M(-0.8%) |
| Jun 2006 | - | $284.91 M(+3.1%) |
| Mar 2006 | - | $276.44 M(-1.5%) |
| Dec 2005 | $280.51 M(+0.7%) | $280.51 M(+7.3%) |
| Sep 2005 | - | $261.54 M(+3.0%) |
| Jun 2005 | - | $254.01 M(-7.6%) |
| Mar 2005 | - | $275.01 M(-1.3%) |
| Dec 2004 | $278.64 M(+40.4%) | $278.64 M(+17.3%) |
| Sep 2004 | - | $237.57 M(+13.5%) |
| Jun 2004 | - | $209.28 M(+3.9%) |
| Mar 2004 | - | $201.37 M(+1.4%) |
| Dec 2003 | $198.52 M(+3935.0%) | $198.52 M(-6.2%) |
| Sep 2003 | - | $211.75 M(+7.4%) |
| Jun 2003 | - | $197.15 M(+10.8%) |
| Mar 2003 | - | $177.97 M(+3517.2%) |
| Dec 2002 | $4.92 M(-97.2%) | $4.92 M(-96.9%) |
| Sep 2002 | - | $158.18 M(-13.0%) |
| Jun 2002 | - | $181.90 M(+5.2%) |
| Mar 2002 | - | $172.94 M(-2.6%) |
| Dec 2001 | $177.58 M(+24.0%) | $177.58 M(+11.7%) |
| Sep 2001 | - | $159.00 M(-4.5%) |
| Jun 2001 | - | $166.46 M(+13.4%) |
| Mar 2001 | - | $146.80 M(+2.5%) |
| Dec 2000 | $143.18 M(+4.2%) | $143.18 M(-1.7%) |
| Sep 2000 | - | $145.69 M(-5.6%) |
| Jun 2000 | - | $154.30 M(+13.9%) |
| Mar 2000 | - | $135.49 M(-1.4%) |
| Dec 1999 | $137.36 M(+35.6%) | $137.36 M(+35.6%) |
| Dec 1998 | $101.28 M(+16.7%) | $101.28 M(+16.7%) |
| Dec 1997 | $86.80 M(+102.1%) | $86.80 M(+102.1%) |
| Dec 1996 | $42.95 M(+119.0%) | $42.95 M(+119.0%) |
| Dec 1995 | $19.61 M(+6.0%) | $19.61 M(+6.0%) |
| Dec 1994 | $18.50 M | $18.50 M |
FAQ
- What is Biogen annual accounts receivable?
- What is the all time high annual accounts receivable for Biogen?
- What is Biogen annual accounts receivable year-on-year change?
- What is Biogen quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Biogen?
- What is Biogen quarterly accounts receivable year-on-year change?
What is Biogen annual accounts receivable?
The current annual accounts receivable of BIIB is $2.10 B
What is the all time high annual accounts receivable for Biogen?
Biogen all-time high annual accounts receivable is $2.49 B
What is Biogen annual accounts receivable year-on-year change?
Over the past year, BIIB annual accounts receivable has changed by -$36.40 M (-1.70%)
What is Biogen quarterly accounts receivable?
The current quarterly accounts receivable of BIIB is $1.99 B
What is the all time high quarterly accounts receivable for Biogen?
Biogen all-time high quarterly accounts receivable is $2.62 B
What is Biogen quarterly accounts receivable year-on-year change?
Over the past year, BIIB quarterly accounts receivable has changed by -$90.10 M (-4.34%)